Your browser doesn't support javascript.
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19.
Strohbehn, Garth W; Reid, Pankti D; Ratain, Mark J.
  • Strohbehn GW; Sections of Hematology/Oncology, Department of Medicine, The University of Chicago Medicine and Biological Sciences, Chicago, Illinois, USA.
  • Reid PD; The Value in Cancer Care Consortium, Ann Arbor, Michigan, USA.
  • Ratain MJ; Section of Rheumatology, Department of Medicine, The University of Chicago Medicine and Biological Sciences, Chicago, Illinois, USA.
Clin Pharmacol Ther ; 108(3): 425-427, 2020 09.
Article in English | MEDLINE | ID: covidwho-505635
ABSTRACT
The global pandemic of coronavirus disease 2019 (COVID-19) represents an emergent threat to the public health. Mitigation strategies have been employed to varying effect in many Western nations. Treatment strategies to effectively address COVID-19 and equitably distribute resources are needed, especially in overwhelmed hospitals.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2020 Document Type: Article Affiliation country: Cpt.1931

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2020 Document Type: Article Affiliation country: Cpt.1931